XCUR EXICURE INC
-
EXICURE INC Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
EXICURE INC (XCUR) reported a loss of $0.18 per share on revenue of $0.00 million for the . .
Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.
Reported Earnings
($0.18)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—